This review highlights the potential of lipidomic and metabolomic biomarkers in predicting breast cancer prognosis and therapy response, enhancing patient care.
The biopharma news we’re paying attention to at ASCO
More than 40,000 people are expected to congregate in Chicago this week for the American Society of Clinical Oncology’s annual meeting, and an estimated 5